Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, cash reserves at Asarina Pharma AB (publ) fell by 10.42m. Cash Flow from Financing totalled 1.00m or -- of revenues. In addition the company used 11.27m for operations while cash from investing was breakeven.
Cash flow per share | -0.5479 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0728 |
---|---|
Tangible book value per share | 0.0728 |
More ▼
Balance sheet in SEKView more
Current ratio | 1.20 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.6064 |
---|---|
Total debt/total capital | 0.3775 |
More ▼